Toyobo Co (3101) AI Stock Analysis

• Market Cap: $80.10B
• Dividend Yield: 4.44%
• Average Volume (3M): 270.34K
• Price to Earnings (P/E): 39.1
• Beta (1Y): 0.60
• Revenue Growth: 1.87%
• EPS Growth: -18.46%
• Country: JP
• Employees: 10,668
• Sector: Industrials
• Sector Strength: 87
• Industry: Chemicals - Specialty
• EPS (TTM): 18.20
• Shares Outstanding: 89,048,790
• 10 Day Avg. Volume: 290,760
• 30 Day Avg. Volume: 270,340
• PEG Ratio: 1.34
• Price to Book (P/B): 0.49
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -2.94
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 60 Neutral
• Price Target: ¥933.00 ▲(4.95%Upside)

Toyobo Co's overall stock score is driven primarily by its financial performance, which shows stable revenue growth and effective cost management but faces challenges in profitability and financial flexibility due to high capital expenditures. Technical analysis indicates mixed market sentiments, with a slight upward momentum. The valuation presents a high P/E ratio, offset by a strong dividend yield, contributing to the stock's moderate attractiveness.

Toyobo Co Business Overview & Revenue Model

Company Description

Toyobo Co., Ltd. provides films and functional polymers, industrial materials, and healthcare and textile products worldwide. It offers industrial films, including PET films for liquid crystal display, optical, and other industrial use; and synthetic papers. The company also provides packaging films, such as PET, polyolefin, and nylon for food packaging, as well as heat-shrink PET films; functional polymers comprising engineering plastics, industrial adhesives, coatings, photo-sensitive printing plates, acrylate polymers, and electronic materials; rubber and coat processing; and pharmaceuticals intermediates. In addition, it offers functional fibers consisting of airbag fabrics; polyethylene and PBO fibers; functional filters for automobiles, indoor, and anti-pollution solvent adsorption materials and units; and fiber materials for automobile parts. Further, the company provides bio products, including enzymes for diagnostics, diagnostic systems, and reagents for research; artificial kidney hollow fibers; anti-clotting materials; seawater desalination modules; functional textiles for sports clothing, underwear, and uniforms; synthetic filaments; apparel under the Munsingwear brand; acrylic fibers under the Exlan brand; and acrylate fibers under the eks brand, as well as trades in textile products. Additionally, it operates as a contract manufacturer of injections. The company was founded in 1882 and is headquartered in Osaka, Japan.

How the Company Makes Money

Toyobo Co., Ltd. generates revenue through the production and sale of its diverse range of products across multiple sectors. In the textiles and fibers sector, Toyobo produces and sells high-quality textiles, functional clothing, and industrial fibers. The company’s chemical division focuses on films and functional polymers, which are used in packaging, electronics, and other applications. Its industrial materials segment offers advanced materials for automotive, construction, and other industries. Additionally, Toyobo’s life science segment includes medical equipment, pharmaceuticals, and biochemical products, contributing to its healthcare solutions. Revenue is also bolstered by strategic partnerships and collaborations with other companies, enhancing its product offerings and expanding its market reach. The company’s focus on research and development drives innovation, creating new products and improving existing ones, which in turn supports its revenue growth.

Toyobo Co Financial Statement Overview

Summary

Toyobo Co demonstrates steady revenue growth and efficient cost management but faces profitability challenges. The balance sheet shows moderate leverage and a balanced capital structure, yet generating shareholder returns remains weak. Cash flow challenges arise from high capital expenditures, affecting financial flexibility.

Income Statement

Toyobo Co has shown a stable revenue growth trend with a 1.87% increase in the latest year. The gross profit margin is robust at 22.99%, indicating effective production cost management. However, net profit margin is low at 0.47%, suggesting pressures on profitability. EBIT and EBITDA margins are moderate, reflecting consistent operational efficiency.

Balance Sheet

The debt-to-equity ratio stands at 1.34, indicating a moderate level of leverage. The equity ratio is 31.61%, suggesting a balanced capital structure. Return on equity is low at 1.03%, highlighting challenges in generating returns from shareholders' equity.

Cash Flow

The company has a negative free cash flow, impacting its financial flexibility. Operating cash flow covers net income well, with a ratio of 14.29, but the free cash flow to net income ratio is negative, reflecting high capital expenditures.

Breakdown
TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement		Total Revenue
421.17B	422.03B	414.26B	399.92B	375.72B	337.41B
	Gross Profit
94.29B	97.06B	88.00B	85.01B	96.13B	90.37B
	EBIT
14.18B	16.65B	8.99B	10.06B	28.43B	26.66B
	EBITDA
28.06B	32.05B	26.75B	29.11B	48.51B	45.75B
	Net Income Common Stockholders
1.60B	2.00B	2.46B	-655.00M	12.87B	4.20B
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
30.69B	28.58B	33.80B	60.70B	27.18B	34.70B
	Total Assets
614.06B	617.80B	606.99B	588.91B	517.77B	491.19B
	Total Debt
253.88B	261.07B	242.09B	225.17B	187.69B	182.92B
	Net Debt
223.19B	232.49B	208.29B	164.46B	160.51B	148.22B
	Total Liabilities
381.57B	385.75B	376.90B	367.48B	320.63B	302.55B
	Stockholders Equity
195.54B	195.31B	197.03B	189.59B	194.88B	185.73B
Cash Flow		Free Cash Flow
0.00	-16.60B	-35.03B	-31.36B	-12.02B	7.53B
	Operating Cash Flow
0.00	28.62B	21.59B	7.80B	17.10B	35.03B
	Investing Cash Flow
0.00	-47.01B	-58.78B	-36.01B	-24.61B	-31.68B
	Financing Cash Flow
0.00	12.61B	8.26B	61.30B	-1.73B	5.34B

Toyobo Co Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 889.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3101, the sentiment is Positive. The current price of 889 is below the 20-day moving average (MA) of 891.80, above the 50-day MA of 883.50, and below the 200-day MA of 919.24, indicating a neutral trend. The MACD of 4.39 indicates Negative momentum. The RSI at 54.34 is Neutral, neither overbought nor oversold. The STOCH value of 62.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3101.

Toyobo Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4369	78 Outperform	¥95.51B	17.74		1.19%	96.61%	133.90%
4028	75 Outperform	¥74.24B	8.32		4.57%	4.87%	5.12%
4008	66 Neutral	¥60.89B	9.65		4.54%	3.21%	-1.94%
Sector *	66 Neutral	$4.51B	12.22	5.40%	3.63%	4.14%	-12.01%
3101	60 Neutral	$80.10B	39.12		4.44%	1.87%	-18.46%
SYCHF		$570.96M	20.75	2.93%	0.03%	―	―
4099		¥85.62B	9.59		2.63%	―	―

Toyobo Co Corporate Events

Toyobo Co. Reports Strong Operating Profit Growth Amidst Decline in Net Profit

Toyobo Co., Ltd. reported a 1.9% increase in net sales for the fiscal year ending March 31, 2025, with operating profit surging by 85.1%. However, profit attributable to owners of the parent declined by 18.4%. The company anticipates significant growth in the upcoming fiscal year, forecasting a 4.3% rise in net sales and a 124.6% increase in profit attributable to owners, indicating a strong outlook for future performance.